Influenza vaccination: a ‘shot’ at INVESTing in cardiovascular health

Keyphrases

• Acute Infection 33%
• Cardiac Injury 33%
• Cardiothoracic 33%
• Cardiovascular Health 100%
• Cardiovascular Risk 66%
• Centerpiece 33%
• Clinical High Risk 66%
• Comparative Effectiveness Studies 33%
• COVID-19 Pandemic 66%
• Favorable Risk 33%
• Handwashing 33%
• High Dose 33%
• High Risk 33%
• Infection Control Measures 33%
• Influenza 33%
• Influenza Incidence 33%
• Influenza Outbreak 33%
• Influenza Vaccination 100%
• Influenza Vaccine 100%
• Low Dose Rate 33%
• Mask Use 33%
• Moral Imperative 33%
• NHLBI 33%
• Observational Data 33%
• Organ-specific 33%
• Patients with Cardiovascular Diseases 33%
• Physical Distancing 33%
• Public Health 33%
• Published Results 33%
• Randomized Controlled Trial 33%
• Risk Mitigation 33%
• Risk-benefit 33%
• Serious Adverse Effects 33%
• Single Administration 33%
• Trial Data 33%
• Underutilization 33%
• Vaccination 33%
• Viral Respiratory Infections 33%

Medicine and Dentistry

• Adverse Event 33%
• Cardiothoracics 33%
• Cardiovascular Disease 33%
• Cardiovascular Risk 100%
• Cardiovascular System 100%
• COVID-19 66%
• Drug Megadose 33%
• Effectiveness Study 33%
• Handwashing 33%
• Health Care Cost 33%
• Heart Injury 33%
• Infection 33%
• Infection Control 33%
• Influenza Vaccination 100%
• Influenza Vaccine 100%
• Injury 33%
• Medicine 33%
• Public Health 33%
• Randomized Controlled Trial 33%
• Side Effect 33%
• Single Drug Dose 33%
• Social Distancing 33%
• Viral Respiratory Tract Infection 33%